Kaken Pharmaceutical Pink Sheet Forward View - Simple Exponential Smoothing
| KKPCF Stock | USD 26.00 0.00 0.00% |
Kaken Pink Sheet outlook is based on your current time horizon. We suggest always using this module together with an analysis of Kaken Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 10th of February 2026 the relative strength index (rsi) of Kaken Pharmaceutical's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Kaken Pharmaceutical hype-based prediction, you can estimate the value of Kaken Pharmaceutical Co from the perspective of Kaken Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Kaken Pharmaceutical Co on the next trading day is expected to be 26.00 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.48. Kaken Pharmaceutical after-hype prediction price | USD 26.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kaken |
Kaken Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Kaken price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kaken using various technical indicators. When you analyze Kaken charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kaken Pharmaceutical Simple Exponential Smoothing Price Forecast For the 11th of February 2026
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Kaken Pharmaceutical Co on the next trading day is expected to be 26.00 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.48, and the sum of the absolute errors of 9.48.Please note that although there have been many attempts to predict Kaken Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kaken Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kaken Pharmaceutical Pink Sheet Forecast Pattern
| Backtest Kaken Pharmaceutical | Kaken Pharmaceutical Price Prediction | Research Analysis |
Kaken Pharmaceutical Forecasted Value
In the context of forecasting Kaken Pharmaceutical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kaken Pharmaceutical's downside and upside margins for the forecasting period are 23.21 and 28.79, respectively. We have considered Kaken Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Kaken Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Kaken Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.5356 |
| Bias | Arithmetic mean of the errors | -0.0333 |
| MAD | Mean absolute deviation | 0.158 |
| MAPE | Mean absolute percentage error | 0.006 |
| SAE | Sum of the absolute errors | 9.48 |
Predictive Modules for Kaken Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kaken Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kaken Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kaken Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Kaken Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kaken Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kaken Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kaken Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Kaken Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kaken Pharmaceutical's historical news coverage. Kaken Pharmaceutical's after-hype downside and upside margins for the prediction period are 23.21 and 28.79, respectively. We have considered Kaken Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kaken Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Kaken Pharmaceutical is based on 3 months time horizon.
Kaken Pharmaceutical Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Kaken Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kaken Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kaken Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.79 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
26.00 | 26.00 | 0.00 |
|
Kaken Pharmaceutical Hype Timeline
Kaken Pharmaceutical is now traded for 26.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kaken is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.16%. %. The volatility of related hype on Kaken Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 26.00. About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.01. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kaken Pharmaceutical last dividend was issued on the 30th of March 2023. The entity had a split on the 28th of September 2015. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Kaken Pharmaceutical to cross-verify your projections.Kaken Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Kaken Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Kaken Pharmaceutical's future price movements. Getting to know how Kaken Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kaken Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LYPHF | Luye Pharma Group | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 49.57 | |
| CSWYF | China Shineway Pharmaceutical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AIHLF | Adcock Ingram Holdings | 0.00 | 0 per month | 0.00 | (0.18) | 0.00 | 0.00 | 2.64 | |
| DGWPF | Drgerwerk AG Co | 0.00 | 0 per month | 0.00 | 0.01 | 0.00 | 0.00 | 7.24 | |
| TRSSF | Terrascend Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PEXXF | PT Tempo Scan | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BTTAY | Biotest Aktiengesellschaft | 0.00 | 0 per month | 0.00 | (0.09) | 0.00 | 0.00 | 6.06 | |
| KSRBF | Kossan Rubber Industries | 0.00 | 0 per month | 0.00 | (0.07) | 0.00 | 0.00 | 6.16 | |
| CCHWF | Columbia Care | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BITGF | Biotage AB | 0.00 | 0 per month | 0.00 | 0.14 | 2.91 | 0.00 | 31.10 |
Other Forecasting Options for Kaken Pharmaceutical
For every potential investor in Kaken, whether a beginner or expert, Kaken Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kaken Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kaken. Basic forecasting techniques help filter out the noise by identifying Kaken Pharmaceutical's price trends.Kaken Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kaken Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Kaken Pharmaceutical could also be used in its relative valuation, which is a method of valuing Kaken Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kaken Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Kaken Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kaken Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Kaken Pharmaceutical pink sheet market strength indicators, traders can identify Kaken Pharmaceutical Co entry and exit signals to maximize returns.
Kaken Pharmaceutical Risk Indicators
The analysis of Kaken Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kaken Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kaken pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.7237 | |||
| Standard Deviation | 2.72 | |||
| Variance | 7.41 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kaken Pharmaceutical
The number of cover stories for Kaken Pharmaceutical depends on current market conditions and Kaken Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kaken Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kaken Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Kaken Pharmaceutical Short Properties
Kaken Pharmaceutical's future price predictability will typically decrease when Kaken Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kaken Pharmaceutical Co often depends not only on the future outlook of the potential Kaken Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kaken Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Last Dividend Date | 30th of March 2023 | |
| Trailing Annual Dividend Rate | 150.00 | |
| Float Shares | 30.87M | |
| Trailing Annual Dividend Yield | 535.71% |
Other Information on Investing in Kaken Pink Sheet
Kaken Pharmaceutical financial ratios help investors to determine whether Kaken Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kaken with respect to the benefits of owning Kaken Pharmaceutical security.